Hemopoietic cell transplantation as curative therapy of myelodysplastic syndromes and myeloproliferative disorders

Bart Scott، نويسنده , , H. Joachim Deeg، نويسنده ,

روزنامه با شماره پیاپی سال 2006

15

519

533

myeloproliferative disorders , myelodysplastic syndromes , Myelofibrosis , co-morbid conditions , cytogenetic risk group , hemopoietic cell transplantation , IPSSscore , organ toxicity , relapse.

Best Practice and Research Clinical Haematology

2006

Best Practice and Research Clinical Haematology

467688